Turning Point Therapeutics, Inc. TPTX
75.49 +75.49
Day range unavailable
52-week range unavailable
News
businesswire.com Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) (“Turning Point”) today announced the expiration of the waiting period under…
businesswire.com TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Turning Point Therapeutics, Inc. (NASDAQ: TPTX) to Bristol Myers Squibb for $76.00 per…
businesswire.com TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Turning Point…
businesswire.com TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Turning Point…
etftrends.com Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point Biotechnology sector-related exchange traded funds were in a bright spot on Friday after Bristol Myers Squibb Co. (NYSE: BMY) said it will acquire drug developers Turning Point Therapeutics…
newsfilecorp.com SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Turning Point Therapeutics, Inc. Buyout Wilmington, Delaware--(Newsfile Corp. - June 3, 2022) - Rigrodsky Law, P.A. is investigating Turning Point Therapeutics, Inc. ("Turning Point") (NASDAQ: TPTX) regarding possible breaches of fiduciary…
gurufocus.com Turning Point Therapeutics' Shares Soar on Bristol-Myers Squibb Deal Turning Point Therapeutics Inc. ( TPTX , Financial) shareholders got a good start to the weekend as the stock soared on news that Bristol-Myers Squibb Co. ( BMY , Financial) is buying the San…
prnewswire.com SHAREHOLDER ALERT: Weiss Law Investigates Turning Point Therapeutics, Inc. NEW YORK , June 3, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Turning Point Therapeutics, Inc.…
invezz.com Here is Why Turning Point Therapeutics Jumped 110% Turning Point Therapeutics Inc (NASDAQ: TPTX) jumped 110% after announcing a definitive merger agreement with Bristol Myers Squibb Co (NYSE: BMY). Under the agreement, Bristol Myers Squibb will…
invezz.com Turning Point Therapeutics shares more than doubled on Friday Shares of Turning Point Therapeutics Inc (NASDAQ: TPTX) more than doubled on Friday after Bristol-Myers Squibb Co (NYSE: BMY) said it will buy the biotech company for $4.10 billion in cash.…
businesswire.com TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Turning Point Therapeutics, Inc. (NASDAQ: TPTX) to Bristol Myers Squibb for $76.00 per…
investorplace.com TPTX Stock Soars 115% as Bristol Myers Announces Takeover of Turning Point Therapeutics Turning Point Therapeutics (TPTX) stock is rocketing higher on Friday following news of a deal with Bristol-Myers Squibb (BMY). The post TPTX Stock Soars 115% as Bristol Myers Announces Takeover of…
benzinga.com Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday.
barrons.com Turning Point Stock Doubles After Bristol Myers Announces Takeover The pharma giant said it would pay $76 a share for the biotech stock, up from Thursday's close of $34.16.
pulse2.com Why Bristol-Myers Squibb (BMY) Is Buying Turning Point Therapeutics (TPTX) In A $4.1 Billion Deal Bristol Myers Squibb (NYSE: BMY) is buying Turning Point Therapeutics, Inc. (NASDAQ: TPTX) in a $4.1 billion deal. These are the details.
marketwatch.com Turning Point Therapeutics stock more than doubles after Bristol Myers buyout deal valuing company at $3.8 billion Shares of Turning Point Therapeutics Inc. TPTX, +2.21% more than doubled, up 116.7%, in premarket trading Friday, after the clinical-stage oncology company agreed to be acquired by biopharmaceutical…
businesswire.com Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company NEW YORK & SAN DIEGO--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) today announced a definitive merger agreement under which…
globenewswire.com Turning Point Therapeutics to Participate in Upcoming Investor Conferences SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer…
marketbeat.com Is Turning Point Therapeutics Stock at a Turning Point? The volatile stock of Turning Point Therapeutics (NASDAQ: TPTX) is once again piquing the interest of high risk traders after the company announced encouraging data related to a pivotal trial.…
stockmarket.com Best Biotech Stocks To Buy Now? 5 To Know Check out these biotech stocks with exciting developments today.
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 524 stocks hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Friday During Friday's session, 445 companies made new 52-week lows.- benzinga.com The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Here's a roundup of top developments in the biotech space over the last 24 hours:
- benzinga.com Earnings Scheduled For November 9, 2021 Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021 Upgrades
benzinga.com Earnings Scheduled For August 9, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.
benzinga.com Earnings Scheduled For May 5, 2021 Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
benzinga.com Stocks Making New 52-Week Highs/Lows For Monday, Feb. 8, 2021 (Via Benzinga Pro's Signals Tool) Highs: KB Home (KBH) Sientra (SIEN) Moderna (MRNA) Veritone (VERI) Marathon Patent Group (MARA) Neogen (NEOG) Toll Brothers (TOL) Veru (VERU) Teledoc Health (TDOC) Foot Locker (FL) Esports…
benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Tuesday During Tuesday's morning session, 342 companies made new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday Monday's morning session saw 240 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday This morning 239 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Friday This morning 221 companies reached new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday During the morning session on Thursday, 186 stocks hit new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Tuesday During Tuesday's morning session, 148 stocks hit new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Friday Before 10 a.m. ET Friday, 72 stocks made new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday During Tuesday's morning session, 78 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday During Monday's morning session, 127 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday On Wednesday, 109 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Monday On Monday, 78 companies set new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Thursday
- benzinga.com Stocks That Hit 52-Week Highs On Friday
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday
- benzinga.com 80 Biggest Movers From Yesterday
- benzinga.com 48 Stocks Moving In Monday's Mid-Day Session
- benzinga.com 60 Biggest Movers From Yesterday
- benzinga.com 46 Stocks Moving In Wednesday's Mid-Day Session
- benzinga.com Stocks That Hit 52-Week Highs On Thursday
- benzinga.com 60 Biggest Movers From Yesterday
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday